Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.52% | -382.15% | -33.98% | -69.58% | -60.59% |
| Total Depreciation and Amortization | -- | 6.43% | -10.68% | 5.85% | -- |
| Total Amortization of Deferred Charges | -- | 20.12% | -30.72% | 25.02% | -- |
| Total Other Non-Cash Items | 135.27% | -6.99% | 36.48% | 3,897.60% | 83.96% |
| Change in Net Operating Assets | -- | 75.47% | 8.76% | -4.02% | -- |
| Cash from Operations | 35.48% | 8.87% | 36.47% | -90.75% | 382.06% |
| Capital Expenditure | 57.44% | 21.84% | -37.01% | -19.67% | -27.11% |
| Sale of Property, Plant, and Equipment | -85.76% | 317.48% | 72.92% | -102.30% | 3,270.00% |
| Cash Acquisitions | -- | -4,737.05% | 92.86% | -36.29% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,025.11% | 749.50% | -111.78% | -4,255.40% | 98.27% |
| Cash from Investing | -442.40% | 1,594.69% | -26.05% | -2,605.05% | 79.16% |
| Total Debt Issued | 48.89% | 36.24% | -1.71% | 14.75% | -18.98% |
| Total Debt Repaid | -284.82% | -143.39% | -38.00% | 7.77% | 51.28% |
| Issuance of Common Stock | 193.90% | -52.37% | 19.45% | -- | -74.16% |
| Repurchase of Common Stock | -- | -807.51% | -- | -269.41% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 11.75% | -76.05% | -6.17% | -238.56% | 31.56% |
| Other Financing Activities | -34.81% | 268.77% | 2.69% | -67.14% | -882.69% |
| Cash from Financing | -4,328.55% | -197.46% | -230.91% | -38.17% | -99.24% |
| Foreign Exchange rate Adjustments | 196.46% | 210.66% | -538.64% | -82.87% | 56.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,625.76% | 117.37% | -65.08% | -861.16% | 109.13% |